A systematic review and meta-analysis of efficacy and safety of Romosozumab in postmenopausal osteoporosis.

Singh, S; Dutta, S; Khasbage, S; Kumar, T; Sachin, J; Sharma, J; Varthya, S B

Singh, S; Dutta, S; Khasbage, S; Kumar, T; Sachin, J; Sharma, J; Varthya, S B.

Afiliación

Singh S; Department of Pharmacology, All India Institute of Medical Sciences, Rajasthan, 342005, Jodhpur, India.
Dutta S; Department of Pharmacology, All India Institute of Medical Sciences, Rajasthan, 342005, Jodhpur, India. siddhartha.dutta87@gmail.com.
Khasbage S; Department of Pharmacology, All India Institute of Medical Sciences, Bhopal, India.
Kumar T; Department of Pharmacology, All India Institute of Medical Sciences, Rajasthan, 342005, Jodhpur, India.
Sachin J; Department of Pharmacology, All India Institute of Medical Sciences, Rajasthan, 342005, Jodhpur, India.
Sharma J; Department of Pharmacology, All India Institute of Medical Sciences, Rajasthan, 342005, Jodhpur, India.
Varthya SB; Department of Pharmacology, All India Institute of Medical Sciences, Rajasthan, 342005, Jodhpur, India.

Osteoporos Int ; 33(1): 1-12, 2022 Jan.

Article en En | MEDLINE | ID: mdl-34432115

Asunto(s)

Conservadores de la Densidad Ósea; Osteoporosis Posmenopáusica; Anticuerpos Monoclonales/efectos adversos; Densidad Ósea; Conservadores de la Densidad Ósea/uso terapéutico; Femenino; Humanos; Osteoporosis Posmenopáusica/tratamiento farmacológico

Palabras clave

Meta-analysis; Osteoporosis; Romosozumab

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Osteoporosis Posmenopáusica / Conservadores de la Densidad Ósea Tipo de estudio: Systematic_reviews Límite: Female / Humans Idioma: En Revista: Osteoporos Int Asunto de la revista: METABOLISMO / ORTOPEDIA Año: 2022 Tipo del documento: Article País de afiliación: India Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google